Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher O'Connor

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
Journal of Psychosomatic Research|September 24, 2009
Coping styles in heart failure patients with depressive symptomsRanak B Trivedi, James A Blumenthal, Christopher O'Connor, et al.
Journal of Cardiac Failure|February 27, 2025
Inertia Is Not an Option: Laying the Foundation for a Consensus on the Assessment of Kidney Function in Acute Decompensated Heart FailureIsabella Cavagna, Mona Fiuzat, Anuradha Lala, et al.
JACC. Cardiovascular Imaging|March 18, 2014
Impaired resting myocardial annular velocities are independently associated with mental stress-induced ischemia in coronary heart diseaseMads Ersbøll, Fawaz Al Enezi, Zainab Samad, et al.
Journal of the American Heart Association|March 30, 2013
Association of anxiety and depression with all-cause mortality in individuals with coronary heart diseaseLana L Watkins, Gary G Koch, Andrew Sherwood, et al.
Psychosomatic Medicine|July 20, 2010
Phobic anxiety and increased risk of mortality in coronary heart diseaseLana L Watkins, James A Blumenthal, Michael A Babyak, et al.
The American Journal of Cardiology|April 12, 2017
Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease)Adam Banks, Samuel Broderick, Karen Chiswell, et al.
Circulation. Cardiovascular Quality and Outcomes|July 8, 2018
Differences Between Patients Enrolled Early and Late During Clinical Trial Recruitment: Insights From the HF-ACTION TrialHaider J Warraich, Christopher O'Connor, Angie Wu, et al.
The Journal of Invasive Cardiology|November 1, 2019
After Action ReviewsAlexander G Truesdell, Behnam Tehrani, Carolyn Rosner, et al.
American Heart Journal|December 22, 2005
Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives: Valsartan Inhibits Platelets (VIP) trialVictor L Serebruany, Alex N Pokov, Alex I Malinin, et al.
Circulation. Heart Failure|December 9, 2017
Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of ElamipretideMelissa A Daubert, Eric Yow, Gary Dunn, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Journal of Psychosomatic Research|September 24, 2009
Coping styles in heart failure patients with depressive symptomsRanak B Trivedi, James A Blumenthal, Christopher O'Connor, et al.
Journal of Cardiac Failure|February 27, 2025
Inertia Is Not an Option: Laying the Foundation for a Consensus on the Assessment of Kidney Function in Acute Decompensated Heart FailureIsabella Cavagna, Mona Fiuzat, Anuradha Lala, et al.
JACC. Cardiovascular Imaging|March 18, 2014
Impaired resting myocardial annular velocities are independently associated with mental stress-induced ischemia in coronary heart diseaseMads Ersbøll, Fawaz Al Enezi, Zainab Samad, et al.
Journal of the American Heart Association|March 30, 2013
Association of anxiety and depression with all-cause mortality in individuals with coronary heart diseaseLana L Watkins, Gary G Koch, Andrew Sherwood, et al.
Psychosomatic Medicine|July 20, 2010
Phobic anxiety and increased risk of mortality in coronary heart diseaseLana L Watkins, James A Blumenthal, Michael A Babyak, et al.
The American Journal of Cardiology|April 12, 2017
Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease)Adam Banks, Samuel Broderick, Karen Chiswell, et al.
Circulation. Cardiovascular Quality and Outcomes|July 8, 2018
Differences Between Patients Enrolled Early and Late During Clinical Trial Recruitment: Insights From the HF-ACTION TrialHaider J Warraich, Christopher O'Connor, Angie Wu, et al.
The Journal of Invasive Cardiology|November 1, 2019
After Action ReviewsAlexander G Truesdell, Behnam Tehrani, Carolyn Rosner, et al.
American Heart Journal|December 22, 2005
Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives: Valsartan Inhibits Platelets (VIP) trialVictor L Serebruany, Alex N Pokov, Alex I Malinin, et al.
Circulation. Heart Failure|December 9, 2017
Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of ElamipretideMelissa A Daubert, Eric Yow, Gary Dunn, et al.
Pageof 14